Furthermore, contrary to the expression of NEDD4-1 in glioma tissues, although the mRNA level showed no difference between the nontumorous and glioma tissues, the protein level of CNrasGEF decreased in human glioma tissues (Figure 6A- D). This evidence concerns the gene RAPGEF2 and central nervous system cancer.